Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein PLAGL2 (PLAGL2) is a C2H2-type zinc finger transcription factor that binds specific DNA sequences and regulates target gene expression, impacting cell proliferation, differentiation, apoptosis, and migration[3][4][5]. PLAGL2 is part of the pleiomorphic adenoma gene (PLAG) family, which is implicated in oncogenesis. In cancer, PLAGL2 has been shown to promote progression by controlling pathways involved in cell cycle and epithelial-mesenchymal transition—such as promoting proliferation and migration in gastric cancer cells through interactions with proteins like USP37 and Snail1[4]. It also plays broader roles in development and in the regulation of stemness and differentiation in some cell types. As with other zinc finger proteins, PLAGL2 executes its functions via DNA-binding and modulation of gene transcription, often acting as a transcriptional activator or repressor depending on the cellular context[3][5][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein PLAGL2 (PLAGL2).